News

The Justice Community Opioid Innovation Network (JCOIN) supports research on quality addiction treatment for OUD in criminal justice settings nationwide.

UK received $8.8 million from NIDA as part of the Justice Community Opioid Innovation Network (JCOIN) to support research on addiction treatment for opioid use disorder in criminal justice settings nationwide.

The College of Social Work (CoSW) at the University of Kentucky has been awarded $2.6 million to support Kentucky families struggling with substance misuse.

The University of Kentucky’s Kentucky Injury Prevention and Research Center (KIPRC) has been awarded a three-year, $23 million grant from the Centers for Disease Control and Prevention (CDC).

The College of Social Work (CoSW) at the University of Kentucky will share in close to $1 billion in federal grants aimed at combating the nation's opioid epidemic.

The University of Kentucky College of Pharmacy will host its tenth annual Therapeutics, Outcomes, Discovery & Delivery (TODD) Symposium from 8 a.m. – 5:30 p.m. on Tuesday, Nov. 12, 2019, in room 124 of the Lee T. Todd, Jr. Building.

Dr. Michelle Lofwall, UK College of Medicine, is one of three national addiction physician experts who led a team of healthcare professionals in developing a new core curriculum designed to educate primary care providers on the prevention, assessment and treatment of substance use disorders (SUD) throughout the continuum of care.

The University of Kentucky has launched a new website for information, news-related updates and excerpts regarding their recently awarded $87 million HEALing Communities Study cooperative agreement.

Few regions have been hit harder by the drug epidemic than Kentucky and need increased access to evidence-based treatment for substance use disorders. The University of Kentucky Department of Psychiatry saw that need and developed a new clinic to better support patients.

Faculty from the Dept of Psychology in the College of Arts & Sciences and Behavioral Science in the College of Medicine have received two, five-year Research Project Grants from the NIH to study neurobehavioral processes involved in drug use disorders.